Rigel Pharmaceuticals (RIGL)
(Delayed Data from NSDQ)
$1.20 USD
+0.05 (4.35%)
Updated May 3, 2024 04:00 PM ET
After-Market: $1.19 -0.01 (-0.83%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/07/2024
Time: AMC |
3/2024 | $-0.03 | 0.00% |
Earnings Summary
For their last quarter, Rigel Pharmaceuticals (RIGL) reported earnings of $0.00 per share, beating the Zacks Consensus Estimate of $-0.03 per share. This reflects a positive earnings surprise of 100.00%. Look out for RIGL's next earnings release on May 07, 2024. For the next earning release, we expect the company to report earnings of -$0.03 per share, reflecting a year-over-year increase of 62.5%.
Earnings History
Price & Consensus
Zacks News for RIGL
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Tops Revenue Estimates
RIGL: What are Zacks experts saying now?
Zacks Private Portfolio Services